Huaxiang Medical
Produces personalized metal 3D printed medical implants and orthopedic devices using selective laser melting (SLM) technology. Core products include porous tantalum and titanium implants for hip/knee reconstruction, spinal fusion cages, and customized solutions for oncologic and revision orthopedic surgery.
- Stage
- Active
- Latest Round
- Bootstrapped
Technology & Products
Key Products
Porous tantalum hip joint filler blocks (3D printed); Personalized porous titanium orthopedic implants; Porous vertebral fusion cages (SLM-based); Intervertebral fusion cages; Degradable zinc alloy implants; Custom metal 3D printed spinal fusion devices
Technological Advantage
Specializes in LPBF-based medical implants using Farsoon equipment, achieving NMPA approvals for porous tantalum and titanium orthopedic devices. First to receive NMPA approval (January 2023) for additively manufactured tantalum intervertebral fusion devices; follow-on approvals include self-stabilizing cervical fusion systems and porous thoracolumbar fusion cages. Products engineered with biomimetic trabecular pore geometry to promote bone integration and fusion. Competitive advantage lies in regulatory clearance pathway and clinical validation in Chinese market; technology is replicable by competitors with access to industrial LPBF systems.
Differentiation
Value Proposition
Reduces surgical lead time and improves osseointegration through personalized geometry. Patient-specific porous implant design eliminates anatomical mismatch, accelerates bone incorporation, and provides reliable load-bearing support for complex defects in tumor reconstruction and revision cases where standard implants are inadequate.
How They Differentiate
Huaxiang Medical differentiates through documented clinical firsts (degradable zinc alloy 2020, porous tantalum spacer 2017) and regulatory approvals for SLM-based porous implants. Offers customization for complex reconstruction cases (tumor, revision surgery) where standard implants fail, contrasting with competitors focused on high-volume serial fusion cages. Early international expansion (Pakistan case 2024/2025) and multi-institutional partnerships demonstrate clinical credibility in competitive set of Chinese medical device makers.
Market & Competition
Target Customers
Hospitals, orthopedic surgeons, spine centers, research institutions
Industry Verticals
Medical Devices; Orthopedic Surgery; Spinal Surgery; Oncologic Reconstruction
Competitors
AK Medical (China-based orthopedic 3D printing); Chunli (orthopedic AM devices); Bond3D (3D printed spinal cages); Shenzhen Dazhou Medical; Sanyou Medical; Wedge Biomedical
Growth & Milestones
Growth Metrics
Multiple NMPA medical device approvals: tantalum metal intervertebral fusion device (January 2023, first approval); self-stabilizing cervical fusion system; porous thoracolumbar fusion cages; titanium alloy intervertebral fusion cage (October 2025). No revenue or customer count disclosed.
Major Milestones
Founded July 2014; First three medical device registrations for SLM-based porous vertebral and intervertebral fusion cages; World-first human implant of degradable zinc alloy orthopedic device (2020); World-first personalized 3D-printed porous tantalum metal spacer implanted in knee revision surgery (2017); TCT Asia 2024 exhibition (3D printing medical application solutions showcased); First international deployment outside mainland China: personalized 3D printed porous hip joint filler block implanted at Ghurki Trust Teaching Hospital, Pakistan (2024/2025)
Notable Customers
Multiple Chinese hospitals and research institutions (unnamed in public sources); Ghurki Trust Teaching Hospital (Pakistan) - first international case 2024/2025